Abstract:The type II-A CRISPR effector SpCas9 has gained widespread popularity as an efficient and programmable genome editing tool. However, much remains to be known about novel compact variants that may overcome some limitations of current systems . Recently, alternative CRISPR-Cas systems with highly compact nucleases capable of genome editing in mammalian cells have been discovered through metagenomic analysis of uncultivated microbes, including Cas9d (a type II-D CRISPR-Cas effector) . Here, we report the cryo-EM structures of a Cas9d nuclease (747 amino acids in length) in multiple functional states, revealing a stepwise process of DNA targeting involving a conformational switch in a REC2 domain insertion. Our structures provide insights into the intricately folded guide RNA which acts as a structural scaffold to anchor small, flexible protein domains and facilitate DNA target recognition. We find that the sgRNA can be truncated by up to ∼25% yet still retain activity . We also show that despite preferentially targeting an NGG PAM, Cas9d exhibits a unique mechanism for PAM recognition. Finally, we identify the first Cas9d smaller than 800 amino acids exhibiting robust nuclease activity in mammalian cells. Using ancestral sequence reconstruction, we demonstrate that it is possible to generate compact nucleases capable of efficient genome editing by expanding the diversity of Cas9d families. Collectively, our results provide mechanistic insights into the evolution and DNA targeting of diverse type II CRISPR-Cas systems, providing a molecular blueprint for future rational re-engineering of minimal RNA-guided DNA nucleases.

Programmable RNA targeting with the single-protein CRISPR effector Cas7-11

Synthetic type III-E CRISPR-Cas effectors for programmable RNA-targeting

Progress of CRISPR‐based Programmable RNA Manipulation and Detection

Progress of CRISPR-based programmable RNA manipulation and detection.

Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors

Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family

Precise transcript targeting by CRISPR-Csm complexes

A New RNA-Dependent Cas12g Nuclease

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications

Cytosolic CRISPR RNA for RNA-targeting CRISPR-Cas systems

Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression

Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes

Programmable RNA targeting with CRISPR-Cas13

Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System

DNA targeting by compact Cas9d and its resurrected ancestor

Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d

RNA editing with CRISPR-Cas13

Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR–Cas Systems

Programmed DNA destruction by miniature CRISPR-Cas14 enzymes

Type III-A CRISPR systems as a versatile gene knockdown technology

EcCas6e-based antisense crRNA for gene repression and RNA editing in microorganisms